OrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 million - ETRA News | RalliesOrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 million
E
ETRA• OrbiMed reports larger indirect stake in Electra Therapeutics
- OrbiMed Advisors, a director and 10% owner, reported a sharp increase in its indirect stake in Electra Therapeutics.
- Indirect holdings rose to 5,126,891 common shares, including 1,333,333 shares bought at USD 15 in the IPO.
- A separate OrbiMed-related position increased to 1,758,279 common shares, including 1,000,000 shares bought at USD 15.
•
